「news一般製品2022年11月10日」の検索結果
175件：146～150件目を表示
-
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
https://www.senju.co.jp/english/products/mytearv.html -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Dry Eye Disease 3 SJP-0132 China Not y
https://www.senju.co.jp/english/rd/trial.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia) Pranoprofeninflammati
http://www.senju.co.jp/english/rd/pipeline.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please chang
http://www.senju.co.jp/english/rd/ -
Mytear Fresh40 | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines Mytear® Fresh40 For blurred vision and eyestrain CHARACTERISTICS With the effects of improved focus adjustment by neostigmine methylsulfate, oxygen uptake into the eyes by pot
http://www.senju.co.jp/english/products/mytearfresh.html